Metabolic Research , Inc.

http://www.metabolicresearchinc.com

Metabolic Research, Inc. (MRI) is a biotechnology company developing a new form of pharmaceutical-grade non-synthetic pharmaceuticals aimed to safely and effectively treat arthritis, heart disease and metabolic and inflammatory diseases. MRI's proprietary process is based on "growing" drugs by using natural metabolic processes of plants or fungus rather than chemical synthesis used by traditional pharmaceutical companies. Although the company plans to use the Agaricus blazei Murrill mushroom and olive leaf extract in this process, many other natural fungi and plants have this potential. The company's research in metabolic pharmaceuticals is in its initial phases, and preliminary research suggests this process could be used to develop safe and highly effective naturally produced pharmaceutical-grade anti-inflammatory, anti-infective and anti-viral substances to fight a broad range of diseases. Metabolic Research, Inc. has recently acquired a license for two provisional patents "Composition and Method of Producing Endogenous Therapeutic Anti-Inflammatory Eicosanoids and their Metabolites by Exogenous or Oral Means," and "Method and Process for Producing Anti-inflammatory Products from Fungi." MRI's long tern game plan calls for using these and other patents to develop both pharmaceutical and natural drugs to effectively treat arthritis, diabetes, hypertension, and other metabolic diseases. MRI's short-term game plan calls for using these patents to develop a natural exercise fitness supplement using an all-natural combination of stem cell recruiters, growth hormone promoters, and mitochrondria energizers to produce accelerated muscle-mass accumulation, raid fat reduction, and significant strength and endurance increases. MRI has just teamed up in a major strategic alliance with Cornerstone Pharmaceuticals, Inc with one of the goals to effectively develop a natural drug for cancer treatment. New experiments at Cornerstone have demonstrated efficacy using this compound against lung cancer.

• 12/8/2013
• 5
• 0